Heteroatom Doped Carbon Dots with Nanoenzyme Like Properties as Theranostic Platforms for Free Radical Scavenging, Imaging, and Chemotherapy

K. Dehvari, Sheng-Hui Chiu, Jin-Sheng Lin, Wubshet Mekonnen Girma, Y. Ling, Jia-Yaw Chang
{"title":"Heteroatom Doped Carbon Dots with Nanoenzyme Like Properties as Theranostic Platforms for Free Radical Scavenging, Imaging, and Chemotherapy","authors":"K. Dehvari, Sheng-Hui Chiu, Jin-Sheng Lin, Wubshet Mekonnen Girma, Y. Ling, Jia-Yaw Chang","doi":"10.2139/ssrn.3527826","DOIUrl":null,"url":null,"abstract":"Carbon-based artificial nanoenzymes have gained increasing interest as emerging and promising nanotheranostic agents due to their biocompatibility, low cost, and straightforward production. Herein, a multifunctional Mn, N, and S incorporated carbon quantum dots (MnNS:CDs) exhibiting scavenging activity against reactive oxygen species (ROS) and reactive nitrogen species (RNS), photoluminescence quantum yield of 17.7 %, and magnetic resonance imaging (MRI) contrast was explored. The optical, magnetic, and antioxidant properties of MnNS:CDs were then regulated by control over Mn incorporation to achieve higher photostability and antioxidant properties. Furthermore, conjugation of MnNS:CDs with hyaluronic acid (HA) (denoted as MnNS:CDs@HA) endowed them with high biocompatibility, which is validated by in vivo studies on zebrafish, and the ability to specifically target cluster determinant 44 (CD44)-overexpressing B16F1 cells, as verified by in vitro confocal and MRI studies. The MnNS:CDs@HA probe with therapeutic antioxidant and dual-modal imaging capability was further assessed for non-covalent binding of doxorubicin (DOX) as a model chemotherapeutic cancer drug. Results showed that targeted delivery and pH-dependent release of DOX elicited apparent cell toxicity (90%) toward B16F1 cancer cells when compared to free DOX treatment group (60%). Benefiting from their intrinsic antioxidant properties, and dual-modal imaging ability, the MnNS:CDs@HA nanocarrier is projected to improve non-invasive targeted diagnosis and therapy.","PeriodicalId":309999,"journal":{"name":"EngRN: Micro & Nano Technologies & Materials (Topic)","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"43","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EngRN: Micro & Nano Technologies & Materials (Topic)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/ssrn.3527826","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 43

Abstract

Carbon-based artificial nanoenzymes have gained increasing interest as emerging and promising nanotheranostic agents due to their biocompatibility, low cost, and straightforward production. Herein, a multifunctional Mn, N, and S incorporated carbon quantum dots (MnNS:CDs) exhibiting scavenging activity against reactive oxygen species (ROS) and reactive nitrogen species (RNS), photoluminescence quantum yield of 17.7 %, and magnetic resonance imaging (MRI) contrast was explored. The optical, magnetic, and antioxidant properties of MnNS:CDs were then regulated by control over Mn incorporation to achieve higher photostability and antioxidant properties. Furthermore, conjugation of MnNS:CDs with hyaluronic acid (HA) (denoted as MnNS:CDs@HA) endowed them with high biocompatibility, which is validated by in vivo studies on zebrafish, and the ability to specifically target cluster determinant 44 (CD44)-overexpressing B16F1 cells, as verified by in vitro confocal and MRI studies. The MnNS:CDs@HA probe with therapeutic antioxidant and dual-modal imaging capability was further assessed for non-covalent binding of doxorubicin (DOX) as a model chemotherapeutic cancer drug. Results showed that targeted delivery and pH-dependent release of DOX elicited apparent cell toxicity (90%) toward B16F1 cancer cells when compared to free DOX treatment group (60%). Benefiting from their intrinsic antioxidant properties, and dual-modal imaging ability, the MnNS:CDs@HA nanocarrier is projected to improve non-invasive targeted diagnosis and therapy.
具有纳米酶样特性的杂原子掺杂碳点作为自由基清除、成像和化疗的治疗平台
碳基人工纳米酶因其生物相容性好、成本低、生产简单等优点,作为新兴的纳米治疗药物受到越来越多的关注。本文研究了多功能Mn、N、S碳量子点(MnNS:CDs)对活性氧(ROS)和活性氮(RNS)具有清除活性,光致发光量子产率为17.7%,并进行了磁共振成像(MRI)对比。通过控制Mn的掺入来调节MnNS:CDs的光学、磁性和抗氧化性能,从而获得更高的光稳定性和抗氧化性能。此外,MnNS:CDs与透明质酸(HA)(表示为MnNS:CDs@HA)结合使其具有高生物相容性,这在斑马鱼的体内研究中得到了验证,并且能够特异性靶向过表达簇决定因子44 (CD44)的B16F1细胞,这在体外共聚焦和MRI研究中得到了验证。MnNS:CDs@HA探针具有治疗性抗氧化和双峰成像能力,进一步评估了多柔比星(DOX)作为模型化疗癌症药物的非共价结合。结果显示,与游离DOX治疗组(60%)相比,DOX的靶向递送和ph依赖性释放对B16F1癌细胞产生了明显的细胞毒性(90%)。得益于其固有的抗氧化特性和双峰成像能力,MnNS:CDs@HA纳米载体有望改善非侵入性靶向诊断和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书